3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Endometrial Neoplasms
4
Lymphedema
3
Neoplasms
2
Melanoma
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Suspected Central Nervous System Tumors
1
Stomach Neoplasms
1
Skull Base Neoplasms
1
Pediatric Patients With Solid Tumors
1
Mixed Tumor, Mesodermal
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Diseases
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholecystitis
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Irinotecan
6
Temozolomide
5
Cyclophosphamide
5
Vincristine
4
Magnetic Resonance Spectroscopy
4
Doxorubicin
4
palbociclib
3
X-Rays
3
Phantoms, Imaging
3
Gemcitabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
olaparib
2
ivosidenib
2
ganitumab
2
eribulin
2
cixutumumab
2
cabozantinib
2
abemaciclib
2
Vemurafenib
2
Specimen Handling
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Peripheral Blood Stem Cell Transplantation
2
Nuclear Medicine Department, Hospital
2
Nivolumab
2
LY3023414
2
FANG vaccine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Ewing
×
Indocyanine Green
×
Clear all
No trials found.